Conference Session & Tracks

This track focuses on the clinical and biological underpinnings of major depressive disorder, exploring its prevalence and impact on individuals. Researchers are invited to present findings on diagnostic criteria, assessment tools, and the latest research in this area.

This session will delve into the relationship between stress and depression, examining how stressors contribute to depressive symptoms. Papers discussing innovative stress and depression assessment tools are encouraged.

This track aims to differentiate between bipolar and unipolar depression, focusing on diagnostic challenges and treatment implications. Contributions that highlight the nuances in symptomatology and management strategies are welcome.

This session will explore the multifactorial causes of depression, including genetic predispositions, cognitive styles, and significant life events. Researchers are invited to present studies that elucidate these complex interactions.

This track will cover various therapeutic modalities for treating depression, including psychotherapies and pharmacological interventions. Presentations on the efficacy and safety of these approaches are highly encouraged.

This session will focus on advancements in cognitive behavioral therapy (CBT) for depression, examining its effectiveness and adaptations for diverse populations. Papers that evaluate CBT outcomes and methodologies are sought.

This track will investigate the spectrum of antidepressants, including SSRIs, tricyclics, and MAOIs, alongside their side effects and safety profiles. Researchers are invited to present clinical trials and meta-analyses in this area.

This session will explore the impact of physical activity on depression and anxiety, discussing mechanisms and clinical implications. Contributions that provide evidence-based insights into exercise as a therapeutic intervention are encouraged.

This track will address the use of electroconvulsive therapy (ECT) in treating severe depression, focusing on current practices, efficacy, and patient outcomes. Researchers are invited to share innovative approaches and findings in this field.

This session will examine the role of vagus nerve stimulation (VNS) in the treatment of depression, including its mechanisms of action and clinical applications. Papers discussing recent advancements and patient experiences with VNS are welcome.

This track will focus on complementary therapies for depression, including mindfulness, acupuncture, and nutritional interventions. Researchers are encouraged to present studies that assess the efficacy and integration of these therapies into conventional treatment paradigms.